Editas Medicine Inc header image

Editas Medicine Inc

EDIT

Equity

ISIN US28106W1036 / Valor 30992799

NASDAQ (2024-11-22)

USD 2.44+2.95%

Editas Medicine Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Editas Medicine Inc is a gene editing company that specializes in developing genomic medicines for a range of diseases using CRISPR gene editing technology. The company's proprietary SLEEK gene editing approach enables high efficiency, multi-transgene knock-in of induced pluripotent stem cells, T cells, and natural killer cells, ensuring robust transgene expression. Editas Medicine works with CRISPR nucleases, including Cas9 and Cas12a, to revise, remove, and replace DNA in a highly targeted manner. The company sees CRISPR as a versatile platform technology with the potential to develop medicines for a wide variety of diseases by targeting DNA in any cell or tissue.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-76.7%1Y

-92.8%3Y

-90.0%5Y

Performance

71.6%1Y

76.1%3Y

79.0%5Y

Volatility

870 M

Market cap (USD)

1,093,439

Daily traded volume (Shares)

2.465 / 2.305

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Autodesk Inc

Autodesk Inc Valor: 910018

Annual Return

-50%0%+50%

Risk level

110

1.86%USD 321.27

Blackbaud Inc

Blackbaud Inc Valor: 1801347

Annual Return

-50%0%+50%

Risk level

110

1.89%USD 86.98

Opera Ltd

Opera Ltd Valor: 42665835

Annual Return

-50%0%+50%

Risk level

110

4.61%USD 20.19

Ardelyx Inc

Ardelyx Inc Valor: 24511822

Annual Return

-50%0%+50%

Risk level

110

3.71%USD 5.31

V-ZUG Holding Ltd

V-ZUG Holding Ltd Valor: 54248374

Annual Return

-50%0%+50%

Risk level

110

1.29%CHF 47.00

Molecular Partners Ltd

Molecular Partners Ltd Valor: 25637909

Annual Return

-50%0%+50%

Risk level

110

0.73%CHF 4.85

Orbis SE

Orbis SE Valor: 1124238

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 5.95

QuantumScape Corporation

QuantumScape Corporation Valor: 58478497

Annual Return

-50%0%+50%

Risk level

110

-0.59%USD 5.04

Duke Energy Corp

Duke Energy Corp Valor: 14115567

Annual Return

-50%0%+50%

Risk level

110

0.98%USD 114.86

Emerson Electric Co

Emerson Electric Co Valor: 928215

Annual Return

-50%0%+50%

Risk level

110

-0.64%USD 128.27

SIX

FactSet

Clearbit

Logos provided by Clearbit